Taping and PMR Effects in Primary Dysmenorrhea

January 1, 2025 updated by: Riphah International University

Combined Effects of Kinesiology Taping and Progressive Muscle Relaxation Technique on Pain, Anxiety and Body Awareness in Primary Dysmenorrhea

The study is randomized controlled trial,The study conducted in two groups. Group A has given the kinesiology taping on the lower abdomen and back for 1-3 days with progressive muscle relaxation technique for 10-20 minutes and a baseline treatment hot pack at a time twice a day from the start of menstruation and Group B has receive the kinesiology taping on the lower abdomen and baseline treatment hot pack without progressive muscle relaxation technique for 1-3 days. The total treatment duration will be 6 weeks. The rationale of this study is to provide empirical evidence regarding the efficacy and safety of kinesiology taping and progressive muscle relaxation. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating K-taping and PMR in primary dysmenorhea. Focusing on the impact of kinesiology taping and progressive muscle relaxation on pain,anxiety, and body awareness aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of kinesiology taping in combination with progressive muscle relaxation technique in primary dysmenorrhea.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 54000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Aged between 18-25 years

    • Unmarried female
    • Taking ≥4 points from Visual Analog Scale during menstrual cycle
    • Had moderate menstrual pain as measured by WaLLID score

Exclusion Criteria:

  • • Complaints of low back pain due to any other pathology, any skin infection, sensitive skin or allergic to Kinesio Tape.

    • PCOD, Uterine/ ovarian tumor, Acute/ chronic pelvic pathology like PID, endometriosis, spinal pathology and deformity
    • Endometrial polyp, having a pelvic infection, using an intrauterine device, having venous congestion in the internal genital organs.
    • Who take analgesic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A
Hot pack+ kinesiology taping + progressive muscle relaxation technique Group A has given the kinesiology taping on the lower abdomen and back for 1-3 days with progressive muscle relaxation technique for 10-20 minutes and a baseline treatment hot pack at a time twice a day from the start of menstruation
Other: hot pack , K taping , Progressive muscle relaxation

Group A has given the kinesiology taping on the lower abdomen and back for 1-3 days with progressive muscle relaxation technique for 10-20 minutes and a baseline treatment hot pack at a time twice a day from the start of menstruation

Group B has receive the kinesiology taping on the lower abdomen and baseline treatment hot pack without progressive muscle relaxation technique for 1-3 days
Experimental: Group B
hot pack + kinesiology taping Group B has receive the kinesiology taping on the lower abdomen and baseline treatment hot pack without progressive muscle relaxation technique for 1-3 days
Other: hot pack , K taping , Progressive muscle relaxation

Group A has given the kinesiology taping on the lower abdomen and back for 1-3 days with progressive muscle relaxation technique for 10-20 minutes and a baseline treatment hot pack at a time twice a day from the start of menstruation

Group B has receive the kinesiology taping on the lower abdomen and baseline treatment hot pack without progressive muscle relaxation technique for 1-3 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
numerical pain rating scale
Time Frame: 1st day
changes from base line NPRS is used to access the pain at 1st day or before the start of menstruation at the end score is calculated by dividing the obtained score by total 0 means no pain and 10 is maximum
1st day
STAI tool (state triate anxiety inventory)
Time Frame: 1st day
changes in the baseline ,STAI tool to access the anxiety of the patient feels at the start of menstruation at the end the score is calculated by dividing the score by total 0 means no anxiety and 4 means maximum anxiety
1st day
Body awareness questionaire
Time Frame: 1st day
Changes in the baseline, Body Awareness Questionnaire (Shields, Mallory & Simon, 1989) acess the body awarenss during dysmenorhea , at the end the score is calcuted 0 means not true of me and 7 is the maximum true of me
1st day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wallid questionaire
Time Frame: 1st day
walid to access the Working ability, Location, Intensity (Wong-Baker) and Days of pain Score: 0 without dysmenorrhea, 1-4 mild dysmenorrhea, 5-7 moderate dysmenorrhea, 8-12 severe dysmenorrhea. Wong-Baker scale was reclassified to adjust a four-level scale.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Iqra abdul ghafoor, PPDPT, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 23, 2023

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

January 1, 2025

First Submitted That Met QC Criteria

January 1, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 1, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/khushbu sohail

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe